Neurocrine Biosciences, Inc. NBIX
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 737.90M | 389.80M | 1.32B | 1.48B | 1.11B |
| Total Receivables | 959.00M | 887.00M | 768.10M | 686.80M | 728.00M |
| Inventory | 66.10M | 104.20M | 64.50M | 69.00M | 69.30M |
| Prepaid Expenses | 212.40M | 217.10M | 224.80M | 170.70M | 178.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 32.80M | 39.40M | 62.50M | 115.80M | 68.20M |
| Total Current Assets | 2.01B | 1.64B | 2.44B | 2.52B | 2.16B |
|
|
|||||
| Total Current Assets | 2.01B | 1.64B | 2.44B | 2.52B | 2.16B |
| Net Property, Plant & Equipment | 529.40M | 538.50M | 538.00M | 545.20M | 566.20M |
| Long-term Investments | 500.60M | 500.60M | -- | -- | -- |
| Goodwill | 500.60M | 500.60M | -- | -- | -- |
| Total Other Intangibles | 2.19B | 2.23B | -- | -- | 35.70M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 251.40M | 217.30M | 455.00M | 379.80M | 388.80M |
| Total Assets | 5.63B | 5.36B | 4.91B | 4.63B | 4.27B |
|
|
|||||
| Total Accounts Payable | 150.50M | 142.00M | 120.00M | 104.90M | 119.90M |
| Total Accrued Expenses | 622.80M | 551.70M | 466.60M | 501.40M | 464.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 59.50M | 59.80M | 57.30M | 56.00M | 51.30M |
| Total Finance Division Other Current Liabilities | 151.80M | 121.00M | 187.80M | 81.10M | 2.40M |
| Total Other Current Liabilities | 151.80M | 121.00M | 187.80M | 81.10M | 2.40M |
| Total Current Liabilities | 984.60M | 874.50M | 831.70M | 743.40M | 638.00M |
|
|
|||||
| Total Current Liabilities | 984.60M | 874.50M | 831.70M | 743.40M | 638.00M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 392.30M | 401.80M | 406.20M | 415.30M | 428.40M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 371.80M | 389.20M | 260.90M | 219.70M | 195.70M |
| Total Liabilities | 1.75B | 1.67B | 1.50B | 1.38B | 1.26B |
|
|
|||||
| Common Stock & APIC | 3.04B | 2.96B | 2.82B | 2.79B | 2.70B |
| Retained Earnings | 838.40M | 724.00M | 589.60M | 447.70M | 294.00M |
| Treasury Stock & Other | 4.40M | 5.10M | 400.00K | 13.10M | 13.20M |
| Total Common Equity | 3.88B | 3.69B | 3.41B | 3.25B | 3.00B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.88B | 3.69B | 3.41B | 3.25B | 3.00B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.88B | 3.69B | 3.41B | 3.25B | 3.00B |
|
|
|||||